After a slow Thanksgiving week, investors made up for lost time with a slew of big-money rounds. VCs spread their cash around ...

Nuvig Therapeutics raises $161 million in Series B funding to advance novel immunomodulatory treatments for autoimmune ...

Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s ...

Investment group Atlas Ventures has closed its fourteenth fund, raising $450 million for the next round of investment in ...